2,6- bis((3,4- dihydroxyphenyl)methylene)cyclohexanone
structure given in first source; binds to nuclear type II sites and mimics methyl 4-hydroxyphenyllactate; inhibits mammary cancer cell growth
Networked: 3
relevant articles (0 outcomes,
2 trials/studies)
Bio-Agent Context: Research Results
Related Diseases
Related Drugs and Biologics